Application 090653
- Type
- ANDA
- Sponsor
- HOSPIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMPICILLIN AND SULBACTAM | AMPICILLIN SODIUM; SULBACTAM SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL | No | No |
| 002 | AMPICILLIN AND SULBACTAM | AMPICILLIN SODIUM; SULBACTAM SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090653-001 | AMPICILLIN AND SULBACTAM | AMPICILLIN SODIUM; SULBACTAM SODIUM | EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2011-12-21 | ||
| A090653-002 | AMPICILLIN AND SULBACTAM | AMPICILLIN SODIUM; SULBACTAM SODIUM | EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2011-12-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090653-001 | AMPICILLIN AND SULBACTAM | EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2011-12-21 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A090653-002 | AMPICILLIN AND SULBACTAM | EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2011-12-21 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 006f9a3f-b4e3-4aa5-ac65-6cc3d3e2582d | 2026-07-22 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | a67ae347-487d-4751-a841-b321e81db26f | 2026-07-21 | Warnings, Adverse reactions | ampicillin and sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 72a37674-8cb2-4b40-aac8-d345ffcf22f2 | 2026-06-23 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 9a722de6-9dc0-4fb9-b63a-225385aa3314 | 2026-06-23 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 77158167-0c1e-4f01-a5b0-a3df8ad121f5 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | e6cf14a8-3ed9-4a7a-ba69-be0b794cbdc4 | 2026-06-10 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Medical Purchasing Solutions, LLC. | 4e81c215-2ab6-87c6-e063-6294a90ac28c | 2026-04-02 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Hikma Pharmaceuticals USA Inc. | a65a70bf-4283-4bc0-b576-00c9ab29bd64 | 2026-03-25 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Hikma Pharmaceuticals USA Inc. | d3026cc0-95d8-44cf-be47-b5ebb8fd4568 | 2026-03-25 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Hospira, Inc | dc374fa4-350b-425d-a7db-7099fdc64cf1 | 2026-01-21 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 437a26f4-776b-4f74-99b2-09ad79831b0c | 2025-12-18 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 16fdfdb9-9e26-48d0-8838-570d30c8e897 | 2025-11-04 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | adc92303-b62b-41c8-becf-9c3a4e8c3a6b | 2025-08-12 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 2709e9fc-2341-4382-af72-c2e3201bd77a | 2025-08-12 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 9f2ff165-2a21-4155-a4f0-57885a83c7dc | 2025-07-24 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Avenacy, LLC | 577dd6f0-d56a-4c82-9f72-274c3a4a0f01 | 2025-04-25 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Avenacy, LLC | 4446d4c8-056d-4bc3-8f58-21255b063398 | 2025-04-25 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 139b4b2e-46f7-44a8-9cc1-774afa463b80 | 2025-04-24 | Warnings, Adverse reactions | Ampicillin and Sulbactam |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | 35606b43-5914-423c-9bc7-fa3957eb2563 | 2024-11-18 | Warnings, Adverse reactions | ampicillin and sulbactam |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | NorthStar Rx, LLC | 5e8d35cb-e93d-42ad-a02c-0dbf04910f61 | 2024-08-13 | Warnings, Adverse reactions | Ampicillin and Sulbactam |